We are live on ! Find out more
ACHN

Achillion Pharmaceuticals
ACHN

Delisted

ACHN was delisted on the 27th of January, 2020.

Back to rankings

132 hedge funds and large institutions have $755M invested in Achillion Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 32 increasing their positions, 43 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more capital invested

Capital invested by funds: $402M → $755M (+$352M)

35% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 31

8% more funds holding

Funds holding: 122 → 132 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

26% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 43

62% less call options, than puts

Call options by funds: $30M | Put options by funds: $78.5M

Holders
132
Holders Change
+10
Holders Change %
+8.2%
% of All Funds
2.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
42
Increased
32
Reduced
43
Closed
31
Calls
$30M
Puts
$78.5M
Net Calls
-$48.4M
Net Calls Change
-$49.5M

Top Buyers

Rank Fund Capital Flow
1
VI
Versor Investments
New York
+$43.5M
2
PCM
Pentwater Capital Management
Florida
+$43.5M
3
MF
Magnetar Financial
Illinois
+$31.8M
4
AA
AQR Arbitrage
Connecticut
+$18.3M
5
WMSA
Weiss Multi-Strategy Advisers
New York
+$16.5M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$37.9M
2
Goldman Sachs
Goldman Sachs
New York
-$18.1M
3
Millennium Management
Millennium Management
New York
-$15.9M
4
UBS Group
UBS Group
Switzerland
-$12M
5
N
Nuveen
North Carolina
-$10.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
OM
26
Opaleye Management
Massachusetts
$4.58M +$4.4M +760,000 New
UBS AM
27
UBS AM
Illinois
$4.31M +$3.08M +532,918 +294%
CS
28
Candriam SCA
Luxembourg
$4.24M -$1.52M -262,369 -27%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.9M +$42.8K +7,398 +1%
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$3.82M +$3.67M +633,598 New
FFM
31
Fairmount Funds Management
Pennsylvania
$3.77M +$3.62M +624,956 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
32
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$3.68M +$3.53M +610,006 New
Two Sigma Advisers
33
Two Sigma Advisers
New York
$3.52M +$69.5K +12,000 +2%
JG
34
Jefferies Group
New York
$3.48M +$3.34M +577,179 New
Millennium Management
35
Millennium Management
New York
$3.31M -$15.9M -2,739,006 -83%
Wellington Management Group
36
Wellington Management Group
Massachusetts
$3.25M +$3.12M +539,028 New
Morgan Stanley
37
Morgan Stanley
New York
$2.86M +$644K +111,253 +31%
IA
38
IndexIQ Advisors
New York
$2.7M +$2.6M +448,355 New
Jane Street
39
Jane Street
New York
$2.7M +$2.52M +436,088 +3,839%
DCM
40
DAFNA Capital Management
California
$2.65M – – –
QI
41
QS Investors
New York
$2.63M -$37.9K -6,548 -1%
Stifel Financial
42
Stifel Financial
Missouri
$2.41M – – –
LOAMU
43
Lombard Odier Asset Management (USA)
New York
$2.31M +$2.22M +383,674 New
GF
44
Gabelli Funds
New York
$2.23M +$2.14M +369,073 New
Walleye Trading
45
Walleye Trading
New York
$2.22M +$2.13M +368,443 New
Two Sigma Investments
46
Two Sigma Investments
New York
$2.08M -$1.92M -331,907 -49%
Balyasny Asset Management
47
Balyasny Asset Management
Illinois
$1.98M +$1.9M +328,985 New
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$1.85M +$535K +92,491 +43%
Capstone Investment Advisors
49
Capstone Investment Advisors
New York
$1.81M +$1.74M +299,906 New
GCIA
50
Gabelli & Co Investment Advisers
New York
$1.75M +$1.68M +291,050 New
1
2
3 4 5

ACHN Hedge Fund Activity: Q4 2019 in Review

132 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q4 2019, worth a combined $755M — up 88% from $402M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new ACHN positions and 31 closed out — a net gain of 11 holders — while 32 added to existing stakes and 43 trimmed.

The largest buyer was Versor Investments, opening a new position worth an estimated $43.5M. The largest seller was RTW Investments, cutting an estimated $37.9M.

  • 132 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q4 2019, up from 122 in Q3 2019.
  • Funds reported $755M of Achillion Pharmaceuticals stock for Q4 2019, up 88% quarter-over-quarter.
  • 42 funds opened new Achillion Pharmaceuticals positions in Q4 2019 and 31 closed out, a net change of +11 holders.
  • The largest Achillion Pharmaceuticals buyer in Q4 2019 was Versor Investments, an estimated $43.5M added.
  • The largest Achillion Pharmaceuticals seller in Q4 2019 was RTW Investments, an estimated $37.9M sold.

Based on aggregated 13F filings for Q4 2019.